Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Antibiotic prophylaxis for gynecologic procedures.

BIBLIOGRAPHIC SOURCE(S)

  • American College of Obstetricians and Gynecologists (ACOG). Antibiotic prophylaxis for gynecologic procedures. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2006 Jul. 10 p. (ACOG practice bulletin; no. 74). [48 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: American College of Obstetricians and Gynecologists (ACOG). Antibiotic prophylaxis for gynecologic procedures. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2001 Jan. 9 p. (ACOG practice bulletin; no. 23).

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

The grades of evidence (I-III) and levels of recommendations (A-C) are defined at the end of "Major Recommendations" field.

The following recommendations and conclusions are based on good and consistent scientific evidence (Level A)

  • Patients undergoing abdominal or vaginal hysterectomy should receive single-dose antimicrobial prophylaxis.
  • Pelvic inflammatory disease (PID) complicating intrauterine device (IUD) insertion is uncommon. The cost-effectiveness of screening for gonorrhea and chlamydia before insertion is unclear; in women screened and found to be negative, prophylactic antibiotics appear to provide no benefit.
  • Antibiotic prophylaxis is indicated for suction curettage abortion.
  • Appropriate prophylaxis for women undergoing surgery that may involve the bowel includes a mechanical bowel preparation without oral antibiotics and the use of a broad-spectrum parenteral antibiotic, given immediately preoperatively.
  • Antibiotic prophylaxis is not recommended in patients undergoing diagnostic laparoscopy.

The following recommendations and conclusions are based on limited or inconsistent scientific evidence (Level B):

  • In patients with no history of pelvic infection, hysterosalpingography (HSG) can be performed without prophylactic antibiotics. If HSG demonstrates dilated fallopian tubes, antibiotic prophylaxis should be given to reduce the incidence of post-HSG PID.
  • Routine antibiotic prophylaxis is not recommended in patients undergoing hysteroscopic surgery.
  • Cephalosporin antibiotics may be used for antimicrobial prophylaxis in women with a history of penicillin allergy not manifested by an immediate hypersensitivity reaction.
  • Patients found to have preoperative bacterial vaginosis should be treated before surgery.

The following recommendations and conclusions are based primarily on consensus and expert opinion (Level C):

  • Antibiotic prophylaxis is not recommended in patients undergoing exploratory laparotomy.
  • Use of antibiotic prophylaxis with saline infusion ultrasonography should be based on clinical considerations, including individual risk factors.
  • Patients with high- and moderate-risk structural cardiac defects undergoing certain surgical procedures may benefit from endocarditis antimicrobial prophylaxis.
  • Patients with a history of anaphylactic reactions to penicillin should not receive cephalosporins.
  • Pretest screening for bacteriuria or urinary tract infection by urine culture or urinalysis, or both, is recommended in women undergoing urodynamic testing. Those with positive results should be given antibiotic treatment.

Definitions:

Grades of Evidence

I Evidence obtained from at least one properly designed randomized controlled trial.

II-1 Evidence obtained from well-designed controlled trials without randomization.

II-2 Evidence obtained from well-designed cohort or case–control analytic studies, preferably from more than one center or research group.

II-3 Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments also could be regarded as this type of evidence.

III Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees.

Levels of Recommendation

Level A — Recommendations are based on good and consistent scientific evidence.

Level B — Recommendations are based on limited or inconsistent scientific evidence.

Level C — Recommendations are based primarily on consensus and expert opinion.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is identified and graded for each recommendation (see "Major Recommendations").

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • American College of Obstetricians and Gynecologists (ACOG). Antibiotic prophylaxis for gynecologic procedures. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2006 Jul. 10 p. (ACOG practice bulletin; no. 74). [48 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2001 Jan (revised 2006 Jul)

GUIDELINE DEVELOPER(S)

American College of Obstetricians and Gynecologists - Medical Specialty Society

SOURCE(S) OF FUNDING

American College of Obstetricians and Gynecologists (ACOG)

GUIDELINE COMMITTEE

American College of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins-Gynecology

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Not stated

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: American College of Obstetricians and Gynecologists (ACOG). Antibiotic prophylaxis for gynecologic procedures. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2001 Jan. 9 p. (ACOG practice bulletin; no. 23).

GUIDELINE AVAILABILITY

AVAILABILITY OF COMPANION DOCUMENTS

Proposed performance measures are included in the original guideline document.

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on September 21, 2004. The information was verified by the guideline developer on December 9, 2004. This NGC summary was updated by ECRI Institute on October 5, 2007. The updated information was verified by the guideline developer on December 3, 2007.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo